274 related articles for article (PubMed ID: 34455966)
1.
Shah U; Patel S; Patel M; Jain N; Pandey N; Chauhan A; Patel A; Patel S
Anticancer Agents Med Chem; 2022; 22(7):1370-1385. PubMed ID: 34455966
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Docking Studies and Biological Activity of New Benzimidazole- Triazolothiadiazine Derivatives as Aromatase Inhibitor.
Acar Çevik U; Kaya Çavuşoğlu B; Sağlık BN; Osmaniye D; Levent S; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Apr; 25(7):. PubMed ID: 32252458
[TBL] [Abstract][Full Text] [Related]
4. Design and Pharmacophore Study of Triazole Analogues as Aromatase Inhibitors.
Banjare L
Anticancer Agents Med Chem; 2024; 24(4):288-303. PubMed ID: 37921212
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors.
Acar Çevik U; Celik I; Işık A; Ahmad I; Patel H; Özkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023 Mar; 41(5):1944-1958. PubMed ID: 35037830
[TBL] [Abstract][Full Text] [Related]
6. Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions.
Seo JI; Yu JS; Zhang Y; Yoo HH
Chem Biol Interact; 2024 Apr; 392():110927. PubMed ID: 38403145
[TBL] [Abstract][Full Text] [Related]
7.
Maruthanila VL; Elancheran R; Mirunalini S
Curr Comput Aided Drug Des; 2022; 18(3):196-212. PubMed ID: 35598239
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
Awasthi M; Singh S; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of New Azole Derivatives as Potent Aromatase Inhibitors with Potential Effects against Breast Cancer.
Kalalinia F; Jouya M; Komachali AK; Aboutourabzadeh SM; Karimi G; Behravan J; Abnous K; Etemad L; Kamali H; Hadizadeh F
Anticancer Agents Med Chem; 2018; 18(7):1016-1024. PubMed ID: 29336269
[TBL] [Abstract][Full Text] [Related]
10. Analogue based drug design, synthesis, molecular docking and anticancer evaluation of novel chromene sulfonamide hybrids as aromatase inhibitors and apoptosis enhancers.
Ghorab MM; Alsaid MS; Al-Ansary GH; Abdel-Latif GA; Abou El Ella DA
Eur J Med Chem; 2016 Nov; 124():946-958. PubMed ID: 27770735
[TBL] [Abstract][Full Text] [Related]
11. In Silico Molecular Interaction Studies of Chitosan Polymer with Aromatase Inhibitor: Leads to Letrozole Nanoparticles for the Treatment of Breast Cancer.
Mishra K; Verma SK; Ratre P; Banjare L; Jain A; Thareja S; Jain AK
Anticancer Agents Med Chem; 2021; 21(9):1191-1199. PubMed ID: 32842946
[TBL] [Abstract][Full Text] [Related]
12. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities,
Alam MS; Lee DU
Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310
[TBL] [Abstract][Full Text] [Related]
13. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
14. New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF-7 breast cancer cell line.
Sobh EA; Khalil NA; Faggal SI; Hassan MSA
Drug Dev Res; 2022 Aug; 83(5):1075-1096. PubMed ID: 35286757
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, investigation of biological effects and in silico studies of new benzimidazole derivatives as aromatase inhibitors.
Sağlık BN; Şen AM; Evren AE; Çevik UA; Osmaniye D; Kaya Çavuşoğlu B; Levent S; Karaduman AB; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2020 Sep; 75(9-10):353-362. PubMed ID: 32681791
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules.
Ghorab MM; Alsaid MS; Samir N; Abdel-Latif GA; Soliman AM; Ragab FA; Abou El Ella DA
Eur J Med Chem; 2017 Jul; 134():304-315. PubMed ID: 28427017
[TBL] [Abstract][Full Text] [Related]
17. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
AboulWafa OM; Daabees HMG; Badawi WA
Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
[TBL] [Abstract][Full Text] [Related]
18. Potent aromatase inhibitors and molecular mechanism of inhibitory action.
Kang H; Xiao X; Huang C; Yuan Y; Tang D; Dai X; Zeng X
Eur J Med Chem; 2018 Jan; 143():426-437. PubMed ID: 29202405
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and docking study of benzimidazole-triazolothiadiazine hybrids as aromatase inhibitors.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2020 May; 353(5):e2000008. PubMed ID: 32159244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
